AKT1 and esophageal squamous cell carcinoma: In addition, BJ-B11, a selective Hsp90 inhibitor, exhibited effective and potent antitumor activity in ESCC cells by inducing autophagy by suppressing the Akt/mTOR/p70S6K signaling pathway in a time- and concentration-dependent manner 147.